Stock Message Boards
ETF Channel
Market News Video Self Directed Investor The Warren Buffetts Next Door Stock message boards Portfolio Channel
RDY Description — Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories is an emerging global pharmaceutical company. Co. derives its revenues from the sale of finished dosage forms, active pharmaceutical ingredients and intermediates, development and manufacturing services, and license fees from its proprietary products segment. Global Generics segment - includes branded and unbranded prescription and over-the-counter drug products business. Pharmaceutical Services and Active Ingredients segment - consists of Co.'s Active Pharmaceutical Ingredient and Custom Pharmaceutical Service business. Proprietary Products segment - consists of Co.'s dermatology focused specialty business operated through Promius™ Pharma.

Company Name:  Dr. Reddy's Laboratories Ltd.
Website:  www.drreddys.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding RDY:  12
Total Market Value Held by ETFs:  $33,399,107
Total Market Capitalization:  $8,305,000,000
% of Market Cap. Held by ETFs:  0.40%
 ETF   RDY Weight   RDY Amount 
 VWO   0.04%   $20,506,726         
 ACWI   0.07%   $4,626,735         
 FNI   4.46%   $3,210,473         
 ACWX   0.09%   $1,624,678         
 CWI   0.27%   $1,619,144         
 EEB   0.44%   $775,048         
 ADRA   1.71%   $474,372         
 BICK   1.67%   $321,488         
 AXJV   1.89%   $100,486         
 ACIM   0.16%   $93,582         
List of all 12 ETFs holding RDY »
10 ETFs With Stocks That Insiders Are Buying
25 Dividend Giants Widely Held By ETFs
25 S.A.F.E. Dividend Stocks Increasing Payments For Decades
Broker Darlings: Top 15 Analyst Picks of the Dow
Top 25 Broker Analyst Picks of the S&P 500
Forgotten S&P 500 Giants: Analysts' Current Least Favorites
25 Top Ranked Socially Responsible Dividend Stocks
10 Oversold ETFs
The Top 10 DividendRank'ed Stocks
The DividendRank Top 25
The Top 10 DividendRank'ed DJIA Components
The Top 10 DividendRank'ed Dow Transports Components
The Top 10 DividendRank'ed Dow Utilities Components
The Top 10 DividendRank'ed Nasdaq 100 Components
10 Stocks Going Ex-Dividend
10 Oversold Dividend Stocks
10 Stocks Where Yields Got More Juicy
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Top Ranked Dividend Stocks With Insider Buying
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Metals Stocks You Can Buy Cheaper Than Insiders Did
10 Oversold Metals Stocks
10 Must-Know High-Yield REITs
10 Top DividendRank'ed Financials
10 Top DividendRank'ed Metals Stocks
10 Oversold Energy Stocks
10 Top DividendRank'ed Energy Stocks
10 Top DividendRank'ed Utility Stocks
10 Stocks Crossing Below Book Value
10 Stocks Crossing Above Their 200 Day Moving Average
10 Stocks Crossing Below Their 200 Day Moving Average
10 ETFs Crossing Above Their 200 DMA
The 10 Biggest ETFs
The 10 Best ETF Performers
The 10 Worst ETF Performers
10 ETFs With Notable Inflows
10 ETFs With Notable Outflows
The Top 10 DividendRank'ed Canadian Stocks
The DividendRank Canada Top 25
10 Canadian Stocks Going Ex-Dividend
10 Oversold Canadian Stocks
10 Canadian Stocks Where Yields Got More Juicy
10 Must-Know High-Yield Canadian Real Estate Stocks
10 Top DividendRank'ed Canadian Financials
10 Must-Know High-Yield Canadian Energy Stocks
10 Canadian Stocks Crossing Below Book Value
10 Canadian Stocks Crossing Above Their 200 Day Moving Avg
10 Canadian Stocks Crossing Below Their 200 Day Moving Avg
Stock market game
Quotes delayed 20 minutes

Hold (2.33 out of 4)
13rd percentile
(ranked lower than approx. 87% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Portfolio Channel

PARTNER NEWS:

Fri, Aug 1, 1:20 PM, Zacks
Dr. Reddy's (RDY) Q1 Earnings and Revenues Rise Y/Y - Analyst Blog
Dr. Reddy's (RDY) reported first-quarter fiscal 2015 earnings per American Depositary Share (ADS) of 54 cents, up 52% and revenues of $586 million, up 24% from the year-ago period .

Thu, Jul 31, 3:15 PM, Zacks
Impax Shares Plunge Post FDA Inspection of Taiwan Facility - Analyst Blog
Shares of Impax Laboratories Inc. (IPXL), which fell 15.2% immediately after the company announced that the FDA has inspected its Taiwan facility, continued to fall in the subsequent trading session.

ETFs Holding RDY | Dr. Reddy's Laboratories Ltd. | ETF Channel | www.ETFChannel.com | Copyright © 2009 - 2014, All Rights Reserved

Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; ETF data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.